US 8652836
Defective ribosomal products in blebs (DRibbles) and methods of use to stimulate an immune response
granted A61KA61K2239/27A61K2239/31
Quick answer
US patent 8652836 (Defective ribosomal products in blebs (DRibbles) and methods of use to stimulate an immune response) held by Providence Health System expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Providence Health System
- Grant date
- Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K2239/27, A61K2239/31, A61K2239/38, A61K2239/49